Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban

Rivaroxaban has been widely used to prevent and treat various thromboembolic diseases for more than a decade. However, whether a lower dose of rivaroxaban is required for Asians is still debatable. This review aimed to explore the potential ethnic difference in pharmacokinetic/pharmacodynamic (PK/PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiao-Qin, Li, Zi-Ran, Wang, Chen-Yu, Chen, Yue-Ting, Jiao, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964148/
https://www.ncbi.nlm.nih.gov/pubmed/36839909
http://dx.doi.org/10.3390/pharmaceutics15020588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964148/
https://www.ncbi.nlm.nih.gov/pubmed/36839909
http://dx.doi.org/10.3390/pharmaceutics15020588

Ejemplares similares